Alison Chesney and Eddie Killoran

The public lectures are held in memory of Alison Chesney and Eddie Killoran, who both died within 6 months of one another, in 2006. Both were well known and respected figures in the drugs field over many years and are still much missed by family, friends and colleagues alike. Following their untimely deaths a number of their friends and former colleagues began discussions to determine what might be a fitting way to remember them. Their families supported the idea of an annual memorial lecture, at which they and the work they undertook might be celebrated by those who knew them and also brought to a wider audience.

Professor Michel Kazatchkine, UN Special Envoy for HIV/AIDS in Eastern Europe and Central Asia

Professor Kazatchkine delivered the fourth Annual Alison Chesney & Eddie Killoran Memorial Lecture, on Monday 4th November 2013, during the City Health 2013 conference in Glasgow. He has spent the past 25 years fighting AIDS and working to improve global health as a leading physician, researcher, advocate, policymaker, diplomat and administrator.

He attended medical school at Necker-Enfants-Malades in Paris, studied immunology at the Pasteur Institute and completed postdoctoral fellowships at St Mary’s hospital in London and Harvard Medical School.

Click here for the video of the lecture.

His involvement with HIV began in 1983, when as a young clinical immunologist he treated a French couple who had returned from Africa with unexplained fever and severe immune deficiency. By 1985, he had started a clinic in Paris specialising in AIDS, which now treats over 1,600 people.

From 1998 to 2005, Professor Kazatchkine directed the French National Research Agency (ANRS), the world’s second largest AIDS research programme. He has produced more than 600 research papers focusing on auto-immunity, drug therapy, immuno-intervention and HIV pathogenesis, in addition to serving on numerous editorial boards.

From 2005 to 2007, Professor Kazatchkine was France’s global ambassador for HIV/AIDS and transmissible diseases. As Ambassador he championed France’s contributions to achieving the Millennium Development Goals and the establishment of Unitaid.

In 2007 he was elected as Executive Director of the Global Fund to Fight AIDS, Malaria and Tuberculosis. In his five years at the helm of the Fund, more than $20 billion in additional donor commitments and pledges were mobilised and he oversaw a major expansion of the Global Fund’s operations and grant portfolio, establishing the Fund as the major international financer of health programs. He strongly emphasised the Fund’s role as a model partnership for development at the national and global levels and promoted innovative approaches to health financing, including Debt2Health and the Affordable Medicines Facility for Malaria. His leadership of the Global Fund consolidated his reputation as one of the world’s leading advocates for health and human rights.

In 2012, Professor Kazatchkine was appointed as the UN Secretary General‘s Special Envoy on HIV/AIDS in Eastern Europe and Central Asia, the part of the world where the AIDS epidemic is expanding at the fastest rate.

Marewa Glover


Read more

Fiona Patten


Read more

David Wilson


Read more

Ruth Dreifuss


Read more

Harry Shapiro


Read more

Sir Harry Burns


Read More

Manuel Carballo


Read more

Michel Kazatchkine


Read more

John Ashton


Read more

Rosalie Pacula


Read More

Gerry Stimson


Read More

City Health International
Founded in 2012 City Health International is a network of individuals and organisations engaged in the study of and response to structural health issues and health behaviours in the urban environment. For the first time in history the majority of the world’s population now live in urban environments and the proportion continues to grow. As national governments struggle to deal with the pressures and demands of growing urban populations against a backdrop of financial deficits and uncertainty, it is increasingly left to those working at a city level to provide the leadership and support needed to tackle key health issues.